Martin Mackay, Ph.D.
About Martin Mackay, Ph.D.
Martin Mackay, Ph.D., Co-Founder and Executive Chairman
Martin Mackay is a highly experienced professional with a significant background in the pharmaceutical and biotech sectors. He currently holds the position of Co-Founder and Executive Chairman. His extensive expertise and leadership have guided his career through several high-profile companies, making notable contributions to firms like Pfizer, AstraZeneca, and Alexion.
Education and Expertise of Martin Mackay, Ph.D.
Martin Mackay obtained a First-Class Honours Degree in microbiology from Heriot-Watt University and further pursued his academic career by earning a Ph.D. in molecular genetics from the University of Edinburgh. This solid educational foundation has been instrumental in his more than 30 years of R&D experience in the pharmaceutical and biotech industries.
Martin Mackay's Professional Background in Pharmaceutical and Biotech R&D
With over 30 years in the pharmaceutical and biotech industries, Martin Mackay has held various leadership roles at prestigious companies such as Pfizer, AstraZeneca, and Alexion. His extensive experience and leadership skills have significantly contributed to the development and growth of these organizations.
Board Memberships and Advisory Roles of Martin Mackay, Ph.D.
Martin Mackay is a respected member of the Board of Directors for Charles River Laboratories and Novo Nordisk. Additionally, he serves as a Senior Advisor at New Leaf Ventures, where he offers his vast knowledge and strategic insights to guide the firm's initiatives.